GlobalTort

GlobalTort

The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy

Category Archives: Science

Subscribe to Science RSS Feed

Marchant and Lindor: “Genomic Malpractice: An Emerging Tide or Gentle Ripple?”

Posted in Medical Malpractice, Science
Yes, there is medical malpractice as to genomic information. The first real study on the topic is from ASU’s Gary Marchant (PhD in genetics and lawyer/law professor) and Rachel Lindor (physician/lawyer). A brief synopsis is provided in a December 5, 2018 post at an ASU law school blog, Bits Bots and Biomarkers.  The full paper… Continue Reading

Another Step in Lung Cancer Screening: GRAIL Announces Plans to Initiate SUMMIT Study in 2019 to Support Development of Blood Test for Early Cancer Detection

Posted in Litigation Industry, Science
Another step forward is happening in the effort to find lung cancers early.  It’s an early detection study – in the UK – using both liquid biopsy and LDCT scans.  The program will start in 2019. The program is a joint effort between Grail, UK government agencies and UK medical centers. The pace of change… Continue Reading

Praedicat Asks: “What’s the risk in learning about risks?”

Posted in Litigation Industry, Mass Tort Issues, Science
It’s an interesting week for thinking about risk. As it happens, I’m presenting on lethal diseases and “real world evidence” at the annual meeting of the Society for Risk Analysis. Meanwhile, the General Counsel of Praedicat recently published an interesting article on:  “What’s the risk in learning about risks?” It’s well worth reading. The article starts… Continue Reading

What Long Term and Possibly Global Actions Will Arise from Massive Failures of Cyber Security: “Marriott: Data on 500 Million Guests Stolen in 4-Year Breach”

Posted in Litigation Industry, Science
The latest global failure of cyber security is covered in detail in a November 30, 2018 post at Krebs on Security, and is headline news around the world. Initial data shows a massive, global scale to the failure. This breach also is only one of many at international and national hotel chains, as explained by Krebs.… Continue Reading

Allianz and Praedicat Expand Access for Manufacturers to Access a System for Enhancing Product Stewardship and Monitoring Product Risks

Posted in Insurance, Insurance Coverage for Tort Claims, Litigation Industry, Science
A press release yesterday brought news of an interesting next step in the process of increasing the intersections between law and molecular science. In short, liability insurance clients of Allianz will receive access to the ChemMeta analytic system developed by Praedicat. The ChemMeta system evaluates scientific literature regarding a selected set of chemicals that are… Continue Reading

Litigating Brain Disease Issues? New Molecular Science News Now on Hand; How Will It Evolve?

Posted in Litigation Industry, Science
Over the years ahead, the term “somatic recombination” may make its way into the lexicon of more lawyers. Why? Because a new, high quality study (published in Nature) shows that brain neurons appear to include mechanisms that intentionally induce somatic changes in brain cells.  Some are calling it a “landmark” study. That said, it is… Continue Reading

Arsenic in Drinking Water, Cancer and Age of Exposure

Posted in Cancer, Litigation Industry, Mass Tort Issues, Science
Age of exposure to toxins is receiving increasing attention from researchers. Below, the abstract from an interesting study of arsenic drinking water exposures in Chile. https://academic.oup.com/aje/article-abstract/187/11/2297/5063615#.W98xc7qmSq8.email “Abstract Arsenic in drinking water is known to cause cancer and noncancer diseases, but little is known about its association with age at exposure. Here, we investigated age at… Continue Reading

Toxic Trio – # 3 – Formaldehyde – Per Allianz and Praedicat

Posted in Litigation Industry, Mass Tort Issues, Science, Uncategorized
As pointed out in Tuesday’s post (September 18, 2018),  Praedicat and Allianz recently published facts and assessments on a “toxic” trio associated with some cosmetics. Again, this is an innovative effort, and deserves careful consideration. The third member of the “toxic trio” substances is formaldehyde. The facts and assessment of the future are – again… Continue Reading

Toxic Trio – # 2 – Toluene – Per Allianz and Praedicat

Posted in Litigation Industry, Mass Tort Issues, Science
As pointed out in Tuesday’s post (September 18, 2018),  Praedicat and Allianz recently published facts and assessments on a “toxic” trio associated with some cosmetics. This is an innovative effort, and one that deserves careful consideration. One of the “toxic trio” substances is toluene. The report includes the following data, and Praedicat’s assessment of where… Continue Reading

Allianz and Praedicat Point Fingers at “Toxic Trio” in Cosmetics – #1 is dibutyl phthalate (DBP)

Posted in Litigation Industry, Mass Tort Issues, Science
A few far sighted liability insurers are paying attention to molecular science as to alleged or actual toxins, often aided by the ground-breaking work at Praedicat to assess the medical and scientific literature as to various actual or alleged toxins. See this February 7, 2014  post regarding Praedicat’s work and vision. Some also are taking… Continue Reading

New Article Touches on Genomics and Causation as to Mesothelioma

Posted in Asbestos, Cancer, Mass Tort Issues, Science
It’s good to see more lawyers focused on genomics as related to causation in mass tort cases. A group from Goldberg Segalla just wrote about the topic as part of a broader paper on alternative causation issues. The article was published in Mealey’s Asbestos; it is: Defense Strategies For Alternative Causation Arguments In Asbestos Case, … Continue Reading

Notable New Study and Paper on 198 Persons with Mesotheliomas and Germline Variants in Cancer Associated Genes

Posted in Asbestos, Cancer, Science
Some scientific findings provide both opportunities and risks for litigants in mass tort cases. The point is highlighted by a new paper by Panou and colleagues published in mid- August in the Journal of Clinical Oncology. The paper concludes that a significant proportion (12%) of patients with malignant mesotheliomas carry inherited (germline) mutations in cancer-associated… Continue Reading

Free Online Access to Evidence from Glyphosate Trial (Johnson Case)

Posted in Cancer, Litigation Industry, Mass Tort Issues, Science
For those of us who are junkies for trials involving alleged or actual toxins, there’s a good resource online for the ongoing Johnson trial involving glyphosate/RoundUp.  The plaintiff’s firm for the ongoing Round Up trial  (the Johnson case) seems to be posting pretty much everything online at the firm’s web site; trial exhibits, trial transcripts… Continue Reading

Respected Stem Cell Scientists Comment On Possible Social Value of Plaintiff Suits Against Some Stem Cell Clinics

Posted in Litigation Industry, Science
Seldom do I see articles in which scientists comment on litigation, much less comment favorably. But two just popped up. One is a brief, comment type article from a respected, well-published stem cell scientist who has been following to some degree lawsuits filed against some “stem cell clinics.”  More specifically, “Dr. Paul Knoepfler (@pknoepfler) is… Continue Reading

“Nightingale Health & UK Biobank announce major initiative to analyze 500,000 blood samples” in 30 months for 200 biomarkers

Posted in Cancer, Science
We continue to see increases in the the scale and pace of the development of molecular and genetic knowledge. A recent example arises from the announcement of serious plans for detailed analysis of 500,000 blood samples for 200 biomarkers. That’s impressive by itself. Then, note the related factors. The new data will be related back… Continue Reading

“Blockchain and the Law CLE Now Available On Demand”

Posted in Offtopic, Science
For those interested in blockchain and CLE, an excellent, on demand program from The Center for Law, Science & Innovation at the ASU Sandra Day O’Connor School of Law. _____________________________________ “The Center for Law, Science & Innovation recently hosted a Blockchain Speaker Series that brought together CEOs, legislators, and legal professionals to discuss present and future legal challenges… Continue Reading

Concussion Trial Underway In Texas – What Did the NCAA Know and When Did It Know It, Featured in Opening Arguments

Posted in Concussion, Litigation Industry, Science
Trial is now underway in a football player’s concussion case against a college (Texas). A June 11, 2018 article at Quartz recaps some of the facts about the plaintiff, and possible implications for the sport at the college level. LAW360 is covering the trial, as is Courtroom View Network. A June 13, 2018 article from… Continue Reading

Molecular Biomarker Revolution and Torts – “Blood Tests Developed That Identify Women at Risk of Preterm Birth”

Posted in Litigation Industry, Science
The molecular biomarker revolution continues and will reshape many topics at the intersections between science and law. A recent example lies in an article explaining that  researchers are moving fruitfully down apath to developing a cheap, non-invasive test to predict risk of pre-term birth. How did they do that? To simplify, tesearchers took a continuing… Continue Reading

Mesothelioma Therapy – Preliminary Report – 1 Complete Response

Posted in Asbestos, Cancer, Science
Therapy with CAR-T cells (artificially modified t-cells) is a “hot” idea these days in cancer therapy.  Last week, the Mesothelioma Applied Research Foundation highlighted some early days, limited success in researchers at MMSK using CAR T cells in a clinical trial setting involving treatment of persons suffering from mesotheliomas; see this May 18, 2018 article. … Continue Reading